Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 3 announcements

Share price: ₹350.05
Market cap: ₹828.1 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 106.4×Sector 50.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Sep 2026 15:03 IST BSE

Annual General Meeting

Bafna Pharmaceuticals Annual General Meeting

Bafna Pharmaceuticals' 31st AGM held on September 11, 2026 approved adoption of audited financials, a director re-appointment, and cost auditor ratification. No specific monetary transaction was transacted.

Read the filing ↗